THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 25 filers reported holding THERAVANCE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,064,000 | -22.0% | 5,625,000 | -26.2% | 0.17% | -20.5% |
Q2 2021 | $7,778,000 | +1.6% | 7,625,000 | 0.0% | 0.22% | -20.4% |
Q1 2021 | $7,658,000 | +0.6% | 7,625,000 | 0.0% | 0.28% | +3.0% |
Q4 2020 | $7,613,000 | +3.9% | 7,625,000 | 0.0% | 0.27% | +0.4% |
Q3 2020 | $7,326,000 | -55.3% | 7,625,000 | -53.9% | 0.27% | -63.5% |
Q2 2020 | $16,388,000 | +6.1% | 16,543,000 | 0.0% | 0.73% | +41.3% |
Q1 2020 | $15,441,000 | -18.3% | 16,543,000 | -11.9% | 0.52% | +61.8% |
Q4 2019 | $18,903,000 | -3.4% | 18,768,000 | -9.5% | 0.32% | +11.5% |
Q3 2019 | $19,576,000 | -14.7% | 20,743,000 | -5.0% | 0.29% | +9.6% |
Q2 2019 | $22,962,000 | -11.6% | 21,843,000 | -14.5% | 0.26% | -19.9% |
Q1 2019 | $25,977,000 | -6.1% | 25,543,000 | 0.0% | 0.33% | -14.2% |
Q4 2018 | $27,666,000 | +6.6% | 25,543,000 | 0.0% | 0.38% | +27.1% |
Q3 2018 | $25,942,000 | +4.3% | 25,543,000 | 0.0% | 0.30% | -2.3% |
Q2 2018 | $24,877,000 | -14.4% | 25,543,000 | -5.5% | 0.31% | -9.2% |
Q1 2018 | $29,055,000 | -6.3% | 27,018,000 | -13.5% | 0.34% | -8.2% |
Q4 2017 | $31,023,000 | +1.3% | 31,218,000 | 0.0% | 0.37% | +10.9% |
Q3 2017 | $30,613,000 | +7.3% | 31,218,000 | 0.0% | 0.33% | +6.1% |
Q2 2017 | $28,525,000 | -3.7% | 31,218,000 | 0.0% | 0.31% | -6.6% |
Q1 2017 | $29,618,000 | +11.3% | 31,218,000 | 0.0% | 0.33% | +21.0% |
Q4 2016 | $26,613,000 | +253.0% | 31,218,000 | +248.8% | 0.28% | +273.0% |
Q3 2016 | $7,540,000 | – | 8,950,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |